Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.
- Conditions
- Interventions
- First Posted Date
- 2024-02-02
- Last Posted Date
- 2024-06-17
- Lead Sponsor
- medac GmbH
- Target Recruit Count
- 212
- Registration Number
- NCT06239311
- Locations
- 🇮🇹
Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
🇵🇱Synexus Polska Sp. Z o.o. Odział w Warszawie, Warszawa, Poland
🇮🇹Universita degli Studi della Campania "Luigi Vanvitelli" - Azienda Ospedaliera Universitaria, Naples, Italy
Trial of Efficacy and Safety of MC0518 Versus Best Available Therapy in Participants with Steroid-Refractory Acute Graft Versus Host Disease
- Conditions
- Interventions
- First Posted Date
- 2023-10-10
- Last Posted Date
- 2024-12-03
- Lead Sponsor
- medac GmbH
- Target Recruit Count
- 48
- Registration Number
- NCT06075706
- Locations
- 🇫🇷
CHU de Bordeaux - Hopital des Enfants, Bordeaux, France
🇫🇷CHU Grenoble Alpes - Hopital Couple Enfant (HCE), La Tronche, France
🇫🇷Centre Hospitalier Universitaire de Lille CHU Lille - Hopital Jeanne de Flandre HJF, Lille, France
Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics
- Conditions
- Interventions
- First Posted Date
- 2022-09-09
- Last Posted Date
- 2024-02-21
- Lead Sponsor
- medac GmbH
- Target Recruit Count
- 36
- Registration Number
- NCT05534620
- Locations
- 🇺🇸
University of Illinois, Chicago, Illinois, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸The Ohio State University, Columbus, Ohio, United States
Treatment of Steroid-Refractory Acute Graft-versus-host Disease with Mesenchymal Stromal Cells Versus Best Available Therapy
- Conditions
- Interventions
- First Posted Date
- 2020-11-16
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- medac GmbH
- Target Recruit Count
- 210
- Registration Number
- NCT04629833
- Locations
- 🇫🇷
Centre Hospitalier Universitaire (CHU) Amiens-Picardie - Hopital Sud, Amiens, France
🇫🇷CHU Jean Minjoz, Besancon, France
🇫🇷CHU de Nantes - Hotel Dieu, Nantes, France
PK, PD, Safety and Immunogenicity of Spectrila in Adults with Acute B-cell Lymphoblastic Leukaemia
- First Posted Date
- 2017-05-17
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- medac GmbH
- Target Recruit Count
- 40
- Registration Number
- NCT03156790
- Locations
- 🇧🇷
Hospital Rio Grande Natal, Rio Grande do Norte, Brazil
🇧🇷Hospital das Clínicas da Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
🇧🇷Universidade Estadual de Campinas, Campinas, Brazil
Clinical Study on 5-aminolevulinic Acid Hydrochloride (5-ALA) for Fluorescence-guided Resection of Malignant Gliomas
- First Posted Date
- 2016-04-28
- Last Posted Date
- 2016-05-23
- Lead Sponsor
- medac GmbH
- Target Recruit Count
- 21
- Registration Number
- NCT02755142
Treosulfan-based Versus Busulfan-based Conditioning in Paediatric Patients With Non-malignant Diseases
- Conditions
- Interventions
- First Posted Date
- 2015-01-29
- Last Posted Date
- 2023-11-03
- Lead Sponsor
- medac GmbH
- Target Recruit Count
- 106
- Registration Number
- NCT02349906
- Locations
- 🇩🇪
University Hospital Frankfurt, Frankfurt am Main, Germany
🇮🇹S.C. Oncoematologia Pediatrica Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
🇮🇹Oncoematologia Pediatrica A.O. di Perugia Ospedale S. Maria della Misericordia, Perugia, Italy
Treosulfan-based Conditioning in Paediatric Patients With Haematological Malignancies
- Conditions
- Interventions
- First Posted Date
- 2015-01-07
- Last Posted Date
- 2020-05-04
- Lead Sponsor
- medac GmbH
- Target Recruit Count
- 70
- Registration Number
- NCT02333058
- Locations
- 🇩🇪
Medical University Hannover, Hannover, Germany
🇩🇪University Clinic Hamburg-Eppendorf, Hamburg, Germany
🇬🇧Birmingham Children's Hospital, Birmingham, United Kingdom
Bioavailability in Patient With Psoriasis: Metoject Prefilled Pen
- First Posted Date
- 2014-03-26
- Last Posted Date
- 2015-03-17
- Lead Sponsor
- medac GmbH
- Target Recruit Count
- 35
- Registration Number
- NCT02097173
- Locations
- 🇺🇸
Clinical Trials of Texas, Inc., San Antonio, Texas, United States
Human Factors Study of Methotrexate Prefilled Pen (50 mg/mL) in Patients With Juvenile Idiopathic Arthritis
- Conditions
- Interventions
- First Posted Date
- 2014-01-31
- Last Posted Date
- 2018-03-29
- Lead Sponsor
- medac GmbH
- Target Recruit Count
- 30
- Registration Number
- NCT02052167
- Locations
- 🇺🇸
Children's Mercy Hospital & Clinics, Kansas City, Missouri, United States